Amycretin showed statistically significant weight loss of up to 14.5% at 36 weeksAmycretin demonstrated statistically ...
The META-AF trial found fewer recurrences of atrial arrhythmias, a benefit unexplained by weight loss or glycemic control.
News-Medical.Net on MSN
Oral GLP-1 pill shows strong weight loss and blood sugar benefits in adults with diabetes
A new oral GLP-1 medication can help adults with obesity and Type 2 diabetes lose more weight and improve their blood sugar ...
ScienceAlert on MSN
New Diabetes Pill Works as Well as Ozempic For Weight Loss, Trial Finds
A major new clinical trial involving more than 1,600 people has found that a GLP-1 pill form of the drug orforglipron works ...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...
Three new studies shed light on some common questions about atrial fibrillation: whether your morning coffee matters, whether ...
Health and Me on MSN
Orforglipron: All You Need To Know About the GLP-1 Pill That Could Replace Weight-Loss Injections
Orforglipron, a new daily GLP-1 pill, could replace weight-loss injections like Wegovy and Ozempic. Studies show it helps ...
We speak to pharmacist Oonagh O’Hagan on everything you need to know about diabetes, from the signs and symptoms, to the ...
GLORY-2 (NCT06164873) is a Phase 3 clinical study to evaluate the efficacy and safety of mazdutide 9 mg combined with lifestyle intervention versus placebo in Chinese adults with obesity (BMI ≥30 ...
Ingredient Supplementation Creates New Category as Industry Addresses Widespread Consumer Confusion About FDA Regulation, ...
The pharma giant said amycretin led to weight loss and diabetes reductions in both injection and pill versions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback